Transcept Pharmaceuticals
Latest round
- Series D
Last raised
- Mar 2007
Total raised
- $71M
Investors
- 9
About Transcept Pharmaceuticals
Founded in 2001 and based in California, US, Transcept Pharmaceuticals, Inc. operates as a specialty pharmaceutical company focusing on the field of neuroscience. Paratek Pharmaceuticals, Inc merged with Transcept Pharmaceuticals in 2014 opearating under the Paratek Pharmaceuticals, Inc, name.
Who invested in Transcept Pharmaceuticals
9 investors across 3 rounds
See all investors in Transcept Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Transcept Pharmaceuticals
Who invested in Transcept Pharmaceuticals?
Transcept Pharmaceuticals has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Transcept Pharmaceuticals raised?
Transcept Pharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Transcept Pharmaceuticals last raise money?
Transcept Pharmaceuticals's most recent round on record is a Series D, in Mar 2007.
What does Transcept Pharmaceuticals do?
Founded in 2001 and based in California, US, Transcept Pharmaceuticals, Inc.
Where is Transcept Pharmaceuticals headquartered?
Transcept Pharmaceuticals is headquartered in US.
Which VCs invest in companies like Transcept Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Transcept Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Transcept Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.